• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经胶质瘤干细胞/祖细胞通过转分化促进血管生成。

Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation.

机构信息

Department of Neurosurgery, The 2nd Affiliated Hospital of Suzhou University, 1055 Sanxiang Road, Suzhou 215004, People's Republic of China.

出版信息

Stem Cell Rev Rep. 2011 Mar;7(1):141-52. doi: 10.1007/s12015-010-9169-7.

DOI:10.1007/s12015-010-9169-7
PMID:20697979
Abstract

OBJECTIVE

Previous studies suggest that tumor cells might be the progenitor for tumor vasculature. Whether vascular tube formation from transdifferentiation of human glioma stem/progenitor cells (hGSPCs) contribute to angiogenesis of gliomas remain largely uncertain.

METHODS

hGSPCs were isolated from thirteen surgical specimens of gliomas and cultured in medium favored for stem cell growth. In vitro transdifferentiation of hGSPCs was performed under hypoxia. Expression of vascular endothelial cells (VECs) markers CD31, CD34, kinase insert domain receptor (KDR), and von Willebrand factor (vWF) were analyzed with real-time quantitative RT-PCR and immunofluorescence techniques. Vasculogenic mimicry of hGSPCs was evaluated in a tumor stem cell xenograft model in vivo. Relationships between content of hGSPCs and expression levels of both VECs markers and proangiogenic factors in large number of clinical specimens were further investigated in glioma tissue microarray.

RESULTS

In vitro, hGSPCs can transdifferentiate into VECs under hypoxia, they manifested typical "flagstone" pattern when cultivated in medium containing VEGF for a few days; when cultivated on Matrigel they were capable of forming capillary-like structures. Expression of VECs markers including CD31, CD34, KDR, and vWF were significantly up-regulated after transdifferentiation. Human leukocyte antigen (HLA) positively stained vessels were observed inside the xenograft tumors after intracerebral transplantation of hGSPCs in athymic nude mice, implied part of tumor cells with human origin were involved in formation of tumor vessels. In surgical specimens of human glioma, tumor vascular cells coexpressing the markers of early VECs (CD34) and markers of hGSPCs (ABCG2 and nestin) suggest that these vascular cells may stemmed from hGSPCs.

CONCLUSIONS

Our observations suggest the functional role of hGSPCs as endothelial progenitors, which have properties that give rise to VECs, and have the ability to form vascular endothelial tubes. However, unspecific markers (ABCG2, nestin) that stain for both endothelial as well as glioma stem cells, were found to be expressed in tumor vasculature of human specimen, and limit further interpretation of this finding.

摘要

目的

先前的研究表明,肿瘤细胞可能是肿瘤血管的前体细胞。人神经胶质瘤干细胞/祖细胞(hGSPCs)的血管管腔形成是否有助于神经胶质瘤的血管生成仍存在很大的不确定性。

方法

从 13 例神经胶质瘤手术标本中分离出 hGSPCs,并在有利于干细胞生长的培养基中培养。在缺氧条件下进行 hGSPCs 的体外转分化。用实时定量 RT-PCR 和免疫荧光技术分析血管内皮细胞(VECs)标志物 CD31、CD34、激酶插入结构域受体(KDR)和血管性血友病因子(vWF)的表达。在体内肿瘤干细胞异种移植模型中评估 hGSPCs 的血管生成拟态。进一步在神经胶质瘤组织微阵列中研究了大量临床标本中 hGSPCs 含量与 VECs 标志物和促血管生成因子表达水平之间的关系。

结果

体外,hGSPCs 在缺氧条件下可向 VECs 转分化,在含 VEGF 的培养基中培养数天后表现出典型的“石板”样形态;在 Matrigel 上培养时,能够形成类似毛细血管的结构。转分化后 VECs 标志物 CD31、CD34、KDR 和 vWF 的表达明显上调。将 hGSPCs 颅内移植入裸鼠后,在异种移植肿瘤内观察到 HLA 阳性染色的血管,提示部分具有人源性的肿瘤细胞参与了肿瘤血管的形成。在人神经胶质瘤的手术标本中,肿瘤血管细胞共同表达早期 VECs 标志物(CD34)和 hGSPCs 标志物(ABCG2 和巢蛋白),提示这些血管细胞可能源自 hGSPCs。

结论

我们的观察表明,hGSPCs 作为内皮祖细胞具有功能性作用,可分化为 VECs,并具有形成血管内皮管的能力。然而,在人标本的肿瘤血管中发现了既表达内皮细胞又表达神经胶质瘤干细胞的非特异性标志物(ABCG2、巢蛋白),限制了对这一发现的进一步解释。

相似文献

1
Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation.神经胶质瘤干细胞/祖细胞通过转分化促进血管生成。
Stem Cell Rev Rep. 2011 Mar;7(1):141-52. doi: 10.1007/s12015-010-9169-7.
2
Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane.敲低P4HA1通过靶向胶质瘤干细胞-内皮细胞转分化和破坏血管基底膜来抑制新生血管形成。
Oncotarget. 2017 May 30;8(22):35877-35889. doi: 10.18632/oncotarget.16270.
3
Transdifferentiation of human MNNG/HOS osteosarcoma cells into vascular endothelial cells in vitro and in vivo.人 MNNG/HOS 骨肉瘤细胞在体外和体内向血管内皮细胞的转分化。
Oncol Rep. 2017 Nov;38(5):3153-3159. doi: 10.3892/or.2017.6005. Epub 2017 Sep 26.
4
[Preliminary studies on cell derivation of neovascularization in human glioma and its functional evaluation].[人胶质瘤新生血管形成的细胞来源及其功能评价的初步研究]
Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):726-31.
5
Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro.人神经胶质瘤干细胞祖细胞的内皮细胞转分化。
Brain Res Bull. 2010 Jul 30;82(5-6):308-12. doi: 10.1016/j.brainresbull.2010.06.006. Epub 2010 Jun 25.
6
MicroRNA-34a induces transdifferentiation of glioma stem cells into vascular endothelial cells by targeting Notch pathway.微小RNA-34a通过靶向Notch信号通路诱导胶质瘤干细胞向血管内皮细胞转分化。
Biosci Biotechnol Biochem. 2017 Oct;81(10):1899-1907. doi: 10.1080/09168451.2017.1364965. Epub 2017 Sep 1.
7
Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells.血管内皮生长因子受体 2(VEGFR-2)在血管生成拟态形成、Glioma 干细胞样细胞的新生血管形成和肿瘤起始中发挥关键作用。
PLoS One. 2013;8(3):e57188. doi: 10.1371/journal.pone.0057188. Epub 2013 Mar 11.
8
A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells.胶质瘤血管生成中的一种新的镶嵌模式:外源性内皮祖细胞整合到含有肿瘤源性内皮细胞的血管中。
Oncotarget. 2014 Apr 15;5(7):1955-68. doi: 10.18632/oncotarget.1885.
9
Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response.动态三维培养中的内皮样恶性胶质瘤细胞确定了VEGF和FGFR在肿瘤源性血管生成反应中的作用。
Oncotarget. 2015 Sep 8;6(26):22191-205. doi: 10.18632/oncotarget.4339.
10
Glioma stem cells involved in tumor tissue remodeling in a xenograft model.神经胶质瘤干细胞参与异种移植模型中的肿瘤组织重塑。
J Neurosurg. 2010 Aug;113(2):249-60. doi: 10.3171/2010.2.JNS09335.

引用本文的文献

1
Endothelial transdifferentiation of glioma stem cells: a literature review.胶质瘤干细胞的内皮转分化:文献综述
Acta Neuropathol Commun. 2025 Aug 21;13(1):181. doi: 10.1186/s40478-025-02031-x.
2
Endothelial cell in tumor angiogenesis: Origins, mechanisms, and therapeutic implication.肿瘤血管生成中的内皮细胞:起源、机制及治疗意义。
Genes Dis. 2025 Mar 24;12(6):101611. doi: 10.1016/j.gendis.2025.101611. eCollection 2025 Nov.
3
Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements.

本文引用的文献

1
PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.PTEN/PI3K/Akt信号通路调控胶质瘤肿瘤干细胞样细胞的侧群表型及ABCG2活性。
Cell Stem Cell. 2009 Mar 6;4(3):226-35. doi: 10.1016/j.stem.2009.01.007.
2
Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.胶质瘤干细胞在伴有恶性进展的复发性肿瘤中比在原发性肿瘤中更具侵袭性,并且二者都能在体外长期维持。
BMC Cancer. 2008 Oct 22;8:304. doi: 10.1186/1471-2407-8-304.
3
Targeting cancer stem cells to modulate alternative vascularization mechanisms.
神经胶质瘤干细胞重塑胶质母细胞瘤中的免疫耐受微环境,并与治疗进展相关。
Cancer Biomark. 2024;41(1):1-24. doi: 10.3233/CBM-230486.
4
CD146, a therapeutic target involved in cell plasticity.CD146,一种涉及细胞可塑性的治疗靶点。
Sci China Life Sci. 2024 Aug;67(8):1563-1578. doi: 10.1007/s11427-023-2521-x. Epub 2024 Apr 9.
5
Glioblastoma stem cell-derived exosomal miR-374b-3p promotes tumor angiogenesis and progression through inducing M2 macrophages polarization.胶质母细胞瘤干细胞衍生的外泌体miR-374b-3p通过诱导M2巨噬细胞极化促进肿瘤血管生成和进展。
iScience. 2024 Feb 22;27(3):109270. doi: 10.1016/j.isci.2024.109270. eCollection 2024 Mar 15.
6
Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma.原发性和复发性胶质母细胞瘤中存在低水平的血管生成拟态。
Cancers (Basel). 2023 Aug 1;15(15):3922. doi: 10.3390/cancers15153922.
7
Cancer Stem Cells in Tumours of the Central Nervous System in Children: A Comprehensive Review.儿童中枢神经系统肿瘤中的癌症干细胞:综述
Cancers (Basel). 2023 Jun 11;15(12):3154. doi: 10.3390/cancers15123154.
8
Considerations for modelling diffuse high-grade gliomas and developing clinically relevant therapies.考虑建立弥漫性高级别神经胶质瘤模型和开发具有临床相关性的治疗方法。
Cancer Metastasis Rev. 2023 Jun;42(2):507-541. doi: 10.1007/s10555-023-10100-7. Epub 2023 Apr 1.
9
Characteristics of vasculogenic mimicry and tumour to endothelial transdifferentiation in human glioblastoma: a systematic review.血管生成拟态和人类脑胶质母细胞瘤向内皮细胞转分化的特征:系统评价。
BMC Cancer. 2023 Feb 23;23(1):185. doi: 10.1186/s12885-023-10659-y.
10
Emerging biomarker in carcinogenesis. Focus on Nestin.肿瘤发生中的新兴生物标志物。聚焦于巢蛋白。
Postepy Dermatol Alergol. 2022 Dec;39(6):1001-1007. doi: 10.5114/ada.2022.122599. Epub 2022 Dec 22.
靶向癌症干细胞以调节替代性血管生成机制。
Stem Cell Rev. 2008 Spring;4(1):51-6. doi: 10.1007/s12015-008-9009-1.
4
Precancerous stem cells can serve as tumor vasculogenic progenitors.癌前干细胞可作为肿瘤血管生成祖细胞。
PLoS One. 2008 Feb 20;3(2):e1652. doi: 10.1371/journal.pone.0001652.
5
Cancer stem cell: target for anti-cancer therapy.癌症干细胞:抗癌治疗的靶点。
FASEB J. 2007 Dec;21(14):3777-85. doi: 10.1096/fj.07-8560rev. Epub 2007 Jul 11.
6
[Expression of cyclin-dependent kinase CDC2 and its significance in malignant progression of gliomas].细胞周期蛋白依赖性激酶CDC2的表达及其在胶质瘤恶性进展中的意义
Zhonghua Bing Li Xue Za Zhi. 2007 Mar;36(3):196-7.
7
Differentiation profile of brain tumor stem cells: a comparative study with neural stem cells.脑肿瘤干细胞的分化特征:与神经干细胞的比较研究。
Cell Res. 2006 Dec;16(12):909-15. doi: 10.1038/sj.cr.7310104.
8
Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.肿瘤基质衍生因子-1将血管祖细胞募集到有丝分裂的新生血管处,在那里微环境会影响它们的分化表型。
Cancer Res. 2006 Sep 15;66(18):9054-64. doi: 10.1158/0008-5472.CAN-05-3759.
9
[Characteristics of morphology, differentiation related marker, and proliferation dynamics of differentiated brain tumor stem cells in vitro].[体外分化脑肿瘤干细胞的形态学、分化相关标志物及增殖动力学特征]
Zhonghua Yi Xue Za Zhi. 2006 Jun 20;86(23):1604-9.
10
ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells.ABCG2(乳腺癌耐药蛋白):正常及恶性干细胞中的一种细胞保护剂。
Clin Adv Hematol Oncol. 2006 Jan;4(1):63-72.